Deni Kukavica1, Alessandro Trancuccio2, Gabriel Brooks3

  • 1Molecular Cardiology Unit, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy. Electronic address: https://x.com/DeniKukavica.

PubMed
概括

设计有效的基因疗法临床试验需要仔细的结果监测和终点选择. 这对于评估治疗疗效和确保患者安全至关重要,特别是考虑到这些疗法的不可逆转性质.